A detailed history of Hrt Financial LP transactions in Evolus, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 36,537 shares of EOLS stock, worth $461,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,537
Holding current value
$461,462
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.66 - $17.48 $389,484 - $638,666
36,537 New
36,537 $591,000
Q1 2024

May 13, 2024

BUY
$9.99 - $14.91 $40,459 - $60,385
4,050 Added 18.31%
26,165 $366,000
Q4 2023

Feb 09, 2024

BUY
$7.6 - $10.53 $9,728 - $13,478
1,280 Added 6.14%
22,115 $232,000
Q3 2023

Nov 13, 2023

BUY
$7.15 - $10.2 $148,970 - $212,516
20,835 New
20,835 $190,000
Q4 2021

Feb 14, 2022

SELL
$5.37 - $8.38 $636,302 - $992,962
-118,492 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$7.36 - $13.67 $872,101 - $1.62 Million
118,492 New
118,492 $902,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $708M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.